GRIFOLS | GRF - Себестоимость





Себестоимость Изменить Дата
Alcon AG USD 1.18B 26M 2026-03
Almirall EUR 199.26M 7.76M 2026-06
Amadeus IT EUR 552M 37.5M 2026-06
Amarin USD 26.05M 1.41M 2025-12
argenx SE USD 145M 24M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Bayer EUR 5.23B 731M 2026-03
Cie Automotive EUR 1.21B 19.7M 2025-12
Demant DKK 2.89B 188M 2025-12
Ence Energia y Celulosa EUR 89.8M 19.53M 2026-03
Essilor EUR 5.55B 505M 2026-06
Ferrovial EUR 1.77B 906M 2026-06
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.43B 248M 2026-03
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Inditex EUR 4.2B 1.99B 2026-03
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.71B 251M 2026-06
Philips EUR 2.21B 70M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
Smith & Nephew USD 901M 31M 2026-06
UCB EUR 1.07B 146M 2025-12
Viscofan EUR 205.04M 12.56M 2026-06